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Abstract 
The durability  of covid-19 immunity in man was  being  explored  in this opinion. Criteria for determination of 
post-recovery protective immunity were  suggested. Current published information indicated that it may last for 
three to six months in accordance with the sero-conversion and sero-prevalence  actual studies. While according 
to memory B and T cell studies ,it was demonstrated  that both of  memory B and memory T cells can be detected 
up to eight months in post recovery  period  of  mild to critical cases  of covid-19  and up to 12 months in a 
retrospective study on large scale seasonal circulating coronavirus human re- infection incidence .Though the 
extent to which  post-recovery  protective B and T cell  immunity operate to re-infection still remain to elucidated. 
Factors affecting the duration of herd immunity to sars-cov-2 were  suggested. basis.      
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1. Introduction 
The pathogenicity of sars-cov-2 virus in man can be attributed to the virus itself or to the indirect immune-
pathogenesis resulted from the immune responses or immune dys-regulation initiated by that responses[Vabret et 
al.2020].Sars-cov-2 virus infection in man induced an array of immunologic consequences that best explained by 
the marked inter-individual variation in severity, infection forms ,and pathology[Vabret et al.2020,,Jesenak et 
al.2020 ].There are six genetic variants[Illarionov &Pivovarova 2020 ],six infection forms[Sudre et al.2020] and 
five duration types[ Branswell 2020].The nature of the post-infection immunity is rather different from that of 
post-vaccination immunity[ Speiser &Bachmann 2020] Duration of the immune protection post to infection or 
post to vaccination means the time period between the presence of the effector immune outcomes in peripheral 
blood stream of the recovered patients and the incident of first natural or experimental re-infection[ Branswell 
2020].While ,the efficacy indicate the ability of patient immune mechanisms to prevents the infection and its 
consequences in post-infection or post-vaccination time periods[ Speiser &Bachmann 2020,Kirkaldy et 
al .2020].The principles of viral herd immunity is just like that of other microbial infections .Though ,the Sars-
cov-2 herd immunity seemed to be quite different ,since the its excessive mortality ,threshold, and 
heterogeneity[Marias & Sorrell 2020] The objective of the present opinion was to focus onto durability of 
immunity in recovered patients and in human herd immunity.  
 
2. Theme  
The theme upon which this opinion organized was that the immunity to covid-19 going to be tackled onto; i-herd 
member[individual] immunity level and ii- herd immunity level. The herd member level immunity was mapped 
into; nature of epitopes, nature of immune response ,immune tissue injuries and nature of the post-recovery 
immunity. Herd immunity level was reviewed and the eligible immune measures put-forwarded .The criteria for 
post-recovery immunity was suggested for individual and for herd so far. 
 
3.Herd member level[Branswell 2020]: 
3.1 Epitope Nature  
Sars-cov-2 virus have an array of several epitopes,like;Th2 B cell dependent epitope like that of spike proteins[Liu 
et al.2020 ],Th1 T Cell dependent epitopes[ Altmann 2020],mucosal invariant T cell epitope [Parrot et al.2020] 
and auto-epitope [ Bastard et al.2020 ]. 
 
3.2 Immune Responses  
The epitopes [II-1] may trigger; I - antibody B cell immune responses[Liu et al. 2020 ] , ii-T cell immune 
response[Altmann 2020], iii-mucosal invariant T cell antiviral responses[Parrot et al.2020 ] and iv- Autoantibody 
responses as anti-cytokine[Bastard et al.2020 ].So far the immune response time curve is concerned,covid-19 
patients have shown dipartite response nature[Stephens &McElrath 2020] as; 
 a-Sero –conversion established within seven to ten days as IgM then class switched to IgG within three weeks 
after infection. 
 b-Sero-conversion established within 14 days as IgM then class switched to I gG within three weeks 
IgM responses can assure current infection .While ,IgG in absence of IgM may indicate clearance of the virus 
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[ Stephens &MacElrath 2020 ].Anti spike protein virus neutralizing antibody is correlated with immune protection 
as held by some workers[Addetetia et al.2020 ]. Auto immune responses to interferon family has been found 
causing life threatening pneumonia due to the effects of the interferon made the patient vulnerable to life 
threatening infections[ Bastard et al. 2020 ] Sars-cov-2 infection activate T cells in the first week of the infection 
and virus specific memory T cells of CD4+ T cells and to lesser extent CD8+ T cells. The T cell responses reported 
to peak within two weeks but remain detectable 100 days or more. On recovery sars-cov-2 specific memory CD4+ 
T cells in 100 % and CD8+ T cell in about 70% of test convalescents[Stephens &McElrath 2020 ].Mucosal 
invariant T cell responses in mild to moderate cases showed lowered numbers in peripheral blood but recruited to 
the respiratory airway niche then re-migrate and homed into the blood stream on recovery of the patients [ parrot 
et al.2020] .Current research have shown that both of memory B and memory T cells remained available in the 
blood stream in post recovery up to six to eight months in mild to severe covid-19 cases[ Sherina et al.2020,Zuo 
et al .2020]. 
 
3.3 Immune Tissue Injuries  
There have been reported numbers of immune tissue injuries accompanied the immune responses during and/or 
post to sars-cov-2 infection or vaccination[ Speiser & Bachmann 2020] such as; Cytokine storm[ Ragab et al. 
2020],micro-thrombi [ McFadyen et al.2020 ],antibody disease enhancement , and T cell disease enhancement 
[Speiser & Bachmann 2020]. 
 
3.4 Post-infection Immunity Scenarios[Branswell 2020]: 
3.4.1 Built in Immunity  
There were  several current supports to the idea of built in immunity  operable in covid-19 as an antibodies with 
virus neutralizing ability specific to spike proteins in subjects whom not exposed to covid-19 disease[Ng et al. 202] 
and CD4 T cells and to lesser extent CD8 T cells in a subjects whom unexposed to Covid-19[Mateus et al. 
20201,Sette &Crotty 2020].These findings were  explained on the bases of cross-immunity with other circulating 
seasonal coronaviruses .Such sort immunity may take part in reducing herd immunity threshold, reduced the 
severity of the infection course and enhance the efficacy of the vaccines[ Ng et al.2020,Mateus et al.2020 ]. 
3.4.2 Sterilizing Immunity[Branswell 2020]:  
It is a state of post-recovery  immunity where the humeral  ,cellular and their  mediator mechanisms can render 
the recovered patients with long  lived immunity  to reinfection as state of measles. The current information  
indicted that the holdings of most covid-19 workers believe  that it far from being operable in covid-19. 
3.4.3 Funcitunal Immunity [Branswell 2020]: 
It is a state of post- recovery  immunity where the effector and/or the memory  immune mechanisms  of the 
recovered patient  are operable on recall of reinfection insults. It seems this scenario is more fitting with the case 
of covid-19. 
3.4.4 Waning Immunity [Branswell 2020]: 
It is a state of post-recovery  immunity where the overall immune mechanisms of the infected patients renders 
them immune till recovery then become declining in due course .Some workers holds that this scenario may be in 
operation in some of the patients. 
3.4.5 Lost or Negative Immunity[Branswell 2020]: 
It is a state of post-recovery  immunity ,where  the net outcomes  of the overall  effector immune mechanisms of 
the recovered patients were used to evade  the infection vajor ,and when recovery was commenced there are no 
functional immune mechanisms at all. Patient  upon re-infection be in a state just like that of first exposure. 
3.4.5 Collective or Mix up Immunity[branswell 2020]: 
Still there are workers whom holds the idea of  mix up scenarios .e.g.Covid-19 herd immunity may sectored based 
on the  assumed scenarios to more than one type of immunity scenarios .Some individuals  were with 
functional ,others with waning or lost. And a third with sterilizing for instance,Table-1. 
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Table 1: Immunity of human to sars-co-2 infection, duration and  possible efficacy in post recovery period* 
Sort of Immunity               Sterilizing         Functional    Waning             Lost 
[9,10,11,12] 
 A –Herd member 
      Effector B cells             +                               +          +                     - 
      Memory B cells            +                               +           +                     - 
      Effector T Cells            +                               +           +                     -        
      Memory T cells            +                               +           +                     - 
      Invariant Mucosal T cells    +                       +            +                     - 
B- Herd Immunity                        Control the infection and Vaccination 
C- Durability              The limits of persistence time period for the memory B and Memory T cells                                  
                                                In the peripheral blood of  convalescents 
D-Efficac The percentages of vitality, morbidity and mortality in natural and                                                     
experimental infection  in vaccinated volunteers  
*Based on  Branswell [2020]. 
 
4 Herd Immune level: 
4.1 :Herd Immunity: 
The herd is a group of individuals living in certain local environment ,the niche .Such individuals do affect each 
other and expresses mutual effect  onto their niche. When an infectious insult contract  this herd ,there are three 
sorts of responses may be traced in this herd ,The individual  response and herd  response as well as the herd effect. 
Herd immunity is a collective general term includes  immune and none-immune factors. The immune factors are; 
past infection, past vaccination as well as the concurrent infections. The none-immune factors are genetic control 
by major histocompatibility complex, nutritional as well as sanitary measures. The herd immune response mapped 
into low, medium and high responders. The distribution of immune individuals within the herd  obey  the normal 
Gaussian distribution curve or it might be of skewd nature[Sette & Crotty 2020 ].To establish herd immunity  to 
any infectious agent  one have to follow either infection or vaccination immunity among the individuals forming 
the herd .If we seek  sars-cov-2 virus infection in the case herd, there should several rounds of  natural infection 
to affect the herd in order to establish an immune herd to this virus. This will cost millions of deaths of the patients. 
The vaccination choice till now  not in hand. There some factor affecting the herd immune  responses such as; 
built in immunity[Ng et al.2020,Mateus et al.2020,Sette & Crotty 2020],reproduction number . limits of 
heterogeneity  , and herd immunity threshold .Presence of built in immunity , herd immunity threshold and low 
heterogeneity  of herd  these all will reduce  the herd immunity threshold .It seems that covid-19 herd immunity 
rather difficult to attain  due to high reproduction number(2-3),marked heterogeneity  ,  marked transmissibility , 
partial protectivity of the neutralizing antibodies induced by the  experimental vaccines in none-human primates 
and in-availability of  human licensed vaccine to date[ Shnawa 2014,Fontanet  &Cauchemez 2020,Sanchez 
2020,Dmarco 2020,Lewis 2020 ].The mathematical model[ Fontanet & Cauchemez  2020] for calculation of the 
reproduction number on the assumption that the individuals forming the herd mix homogenously and are equally 
susceptible  and contagious is as 
R=(1-Pc)(1-P1)Ro…….(question 1) 
Where  Pc is the relative reduction in transmission rates due to none-drug intervention,P1 is the proportion of the 
immune individuals and Ro is  the reproduction number in the absence of control measures in fully susceptible 
population .Ro may vary across the herd over time depending on the nature and number of contacts among herd 
and potential environmental factors. In absence of control measures Pc equal to zero the condition for herd 
immunity( R equal to less than one where  
R=(1-P1)Ro ……. (question  2) is therefore  achieved  when proportion of immune individuals  
reaches P1=1-1/Ro……………(question  3),Table  2. 
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Ro  Effective 
Ro limits 
Death % Measures Determinant of effective 
herd immunity near 50-
60% 
Uncontrolled  2 ? High Prolonged lock down ,short 
term locked down, 




- all of the three 




-on-off physical distancing 
-on-off isolation 







< 1 Effective Low -Active Case  testing 
-Hyper-vigilance and 
extensive testing 
-Active case finding 
-Prolonged lockdown 
As above 
*Based on; Marias and  Sorrell [2020]. 
 
5.Durability: 
5. 1:Individual level; 
The duration of an efficient immunity for human or zoonotic infections can be life- long immune protection or  
say for three years .Or less than one year as counted in months post infection or post vaccination .It is mainly  
dependent on the viability and function of memory B and T cells .By duration of immune efficacy we mean the 
time period  between the presence of immune response outcomes and being effective in prevention of natural or 
experimental challenge with life infective virus. Immune durability in covid-19 convalescents can be judged  by 
the following determinants; 
• The  time period for availability  and efficacy of the anti-spike  neutralizing antibodies in the  post recovery 
patients[Wajnberg et al. 2020,Figueiredo-Campose et.al. 2020]. 
• The time period for the availability of  effector and memory B cells in the peripheral blood of convalescent 
in post recovery patients[Wajinberg et al. 2020]. 
• The time period for the availability of the effector and memory T cells in the peripheral blood of 
convalescent in post recovery patients[Lebert et al. 2020]. 
• Retrospective studies for the seasonal coronavirus records for prolonged time period to map the period of 
reinfections post to recovery[Edridge et al. 2020]. 
• Detailed study to the records  available for covid -19 re-infected patients. 
The duration of neutralizing anti-spike antibodies were determined in actual field large scale studies were 
three months in one study[Wajnberg  et al,2020] and six months in other study[Figueiredo-Campose 2020] and 
retrospective mapping to seasonal actual coronovirus re-infection initiation was evident to be 12 months[Edridge 
et al. 2020] .The efficacy of such antibodies to prevention of re-infection still a matter of debate. Some workers 
holds the idea that neutralizing antibodies are protective[ Addetetia et al. 2020 ] others however does not  holds 
such believe. Both of memory B and T cells lasts for up to six to eight months post recovery in  mild to severe 
covid-19 cases [ Zuo et al.2020,Sherina et al.2020]. 
 
5.2:Herd level[ Sanchez 2020,Dmarco 2020,Lewis 2020,Fontanet &Cauchemez 2020]: 
The durability of human herd immunity to Sars-cov-2 infection largely determined by; 
• Nature of the pathogen 
• Strength of the Individual immune system function 
• Percent of immune individuals within the herd 
• Infection exposure limits and number of infection waves affecting the herd 
• Availability  and coverage extent of vaccination programs  
• Presence of Pre-immunity or built-in  immunity.  
For sure the availability(duration)  of ;virus neutralizing antibodies for three to 6 months and T cell subsets 
for up to  three to eight months  were taken as an overall of medium to large size population studies .  Results 
below and above of these limits were not uncommon to be  reported among individuals forming herds. But still 
the duration of immune protection among the herd is a matter of  debate [ Zuo et al.2020,Sherins at al.2020].  
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6. Concluding Remarks: 
There is no doubts  about the nature of immunity to Sars-cov-2 virus human infection initiated humeral anti-spike 
neutralizing antibody ,effector B cell, effector T cell ,memory  B cell and memory T cell are the foundations of 
infection and re-infection recall immunity. Effector B and effector T cell important in the first exposure and during 
infection till recovery. Memory B and memory T cells supposed to be operable onward  upon re-exposure or re-
infection .Built-in immunity as a sort of humeral and cellular cross or shared immunity take part in reduction of  
disease severity, reduction of herd immunity  threshold, and may enhance vaccine efficacy.Sars-cov-2 human 
infection associated immunity is least probable to be associated with disease enhancement, while the post-
vaccination immunity can be in association with antibody or T cell disease enhancement.Covid-19 herd immunity 
is rather difficult to attain   in  natural infection since it need at least  several round of infections  to pass in herd a 
matter which may leave millions of deaths till reaching  50% herd  immunity threshold due to marked heterogeneity  
of the herd member responses. The most likely speculated durability of post infection immunity was ranging 
between  three ,six ,eight  up  to 12 months. Efficacy of post infection immune  response on reinfection  remained 
to be more elucidated . 
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